To verify that SHP-1 or -2 inhibition promotes immune-mediated, rather than tumor cell-intrinsic, tumor cell elimination, anti-CD3/CD28 activated splenocytes were co-cultured in vitro with 393P or 344SQ KP lung cancer cells in the presence or absence of TPI-1 or SHP099 at increasing concentrations. This evidence concerns the gene TPI1 and lung cancer.